New Delhi: A study by the MEDICAL SERVICES (AFMS) armed forces have found that the Covishield vaccine reduced Covid-19 fresh infection of 93 percent and a death of 98 percent, the Ministry of Defense said on Tuesday.
Data 15.95 Lakh Health Workers and frontline workers – which were given a covishield vaccine – from the Indian armed forces were analyzed for this study, recorded ministries.
India starts the vaccination drive on January 16.
The 15.95 lakh worker mentioned above is between the first covishield vaccine receiver.
“According to this study, there was a reduction of 93 percent in fresh infections and deaths were reduced by 98 percent.
Maybe the biggest research throughout the world in the effectiveness of the Covid-19 vaccine, so far,” said the Ministry of Defense statement mentioned.
This study is mostly done in healthy men with a little co-morbid disease, the ministry said.
“That (study) does not include children and parents.
In a Vin-Win study, the author calculates the incidence and incident level rates,” the Ministry said.
Deputy Admiral Rajat Datta, Director General, AFMS, stated that this research was conducted on anonymous data from the health supervision system that had been enhanced to monitor Covid-19.
“The supervision system has data for daily vaccinations with the first and second doses, the date of positive testing for Covid-19 and Covid deaths; which was analyzed,” said the Ministry of Defense.
This research occurred when the nation witnessed the second wave of pandemic, he said.
“Even so, a group that was fully vaccinated up to 82 percent of the 15.95 lakh showed seven deaths,” mentioned.
Covishield reduces 93% fresh infection, 98% death: AFMS study
